Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 9, 2013 - Issue
Submit an article Journal homepage
300
Views
8
CrossRef citations to date
0
Altmetric
Review

Update on optimal use of lisdexamfetamine in the treatment of ADHD

Vishal MadaanDepartment of Psychiatry and Neurobehavioral Sciences, Division of Child and Family Psychiatry, University of Virginia Health System, Charlottesville, VA, USACorrespondence[email protected]
,
Venkata KolliDepartment of Psychiatry and Neurobehavioral Sciences, Division of Child and Family Psychiatry, University of Virginia Health System, Charlottesville, VA, USA
,
Durga P BesthaDepartment of Psychiatry and Neurobehavioral Sciences, Division of Child and Family Psychiatry, University of Virginia Health System, Charlottesville, VA, USA
&
Manan J ShahDepartment of Psychiatry and Neurobehavioral Sciences, Division of Child and Family Psychiatry, University of Virginia Health System, Charlottesville, VA, USA
Pages 977-983 | Published online: 22 Jul 2013

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Jadwiga Najib, Ekaterina Didenko, Daria Meleshkina, Kamila Yusupov, Kateryna Maw, Justin Ramnarain & Maliha Tabassum. (2020) Review of lisdexamfetamine dimesylate in children and adolescents with attention deficit/hyperactivity disorder. Current Medical Research and Opinion 36:10, pages 1717-1735.
Read now
Benchalak Maneeton, Narong Maneeton, Surinporn Likhitsathian, Sirijit Suttajit, Assawin Narkpongphun, Manit Srisurapanont & Pakapan Woottiluk. (2015) Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials. Drug Design, Development and Therapy 9, pages 1927-1936.
Read now
Narong Maneeton, Benchalak Maneeton, Sirijit Suttajit, Jirayu Reungyos, Manit Srisurapanont & Stephen D Martin. (2014) Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD. Drug Design, Development and Therapy 8, pages 1685-1693.
Read now
Carlos Roncero & F Javier Álvarez. (2014) The use of lisdexamfetamine dimesylate for the treatment of ADHD and other psychiatric disorders. Expert Review of Neurotherapeutics 14:8, pages 849-865.
Read now

Articles from other publishers (4)

Hueng-Chuen Fan, Kuo-Liang Chiang, Kuang-Hsi Chang, Chuan-Mu Chen & Jeng-Dau Tsai. (2023) Epilepsy and Attention Deficit Hyperactivity Disorder: Connection, Chance, and Challenges. International Journal of Molecular Sciences 24:6, pages 5270.
Crossref
M. Lynn Crismon, Janet Walkow & Roger W. Sommi. 2023. Drug Development in Psychiatry. Drug Development in Psychiatry 131 167 .
Carlos Ramos-Galarza & Claudia Pérez-Salas. (2018) Moderator Role of Monitoring in the Inhibitory Control of Adolescents With ADHD. Journal of Attention Disorders 25:2, pages 188-198.
Crossref
María Eugenia Russi. (2018) Experiencia en la utilización de lisdexanfetamina en el manejo del TDAH de niños y adolescentes. Revista de Psiquiatría Infanto-Juvenil 35:3, pages 241-249.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.